Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics EBITDA Margin 2010-2025 | CORT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Corcept Therapeutics (CORT) over the last 10 years. The current EBITDA margin for Corcept Therapeutics as of March 31, 2025 is .
  
Corcept Therapeutics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.69B $0.10B 14.87%
2024-12-31 $0.68B $0.13B 18.93%
2024-09-30 $0.63B $0.14B 21.62%
2024-06-30 $0.57B $0.12B 21.05%
2024-03-31 $0.52B $0.12B 22.14%
2023-12-31 $0.48B $0.10B 20.70%
2023-09-30 $0.45B $0.10B 22.62%
2023-06-30 $0.43B $0.10B 23.78%
2023-03-31 $0.41B $0.10B 24.88%
2022-12-31 $0.40B $0.12B 29.35%
2022-09-30 $0.40B $0.14B 34.17%
2022-06-30 $0.39B $0.14B 36.22%
2022-03-31 $0.38B $0.14B 37.01%
2021-12-31 $0.37B $0.13B 36.61%
2021-09-30 $0.35B $0.12B 34.56%
2021-06-30 $0.34B $0.11B 32.07%
2021-03-31 $0.34B $0.11B 33.53%
2020-12-31 $0.35B $0.13B 36.72%
2020-09-30 $0.36B $0.14B 37.92%
2020-06-30 $0.35B $0.14B 40.91%
2020-03-31 $0.34B $0.13B 39.70%
2019-12-31 $0.31B $0.11B 37.13%
2019-09-30 $0.29B $0.10B 35.31%
2019-06-30 $0.27B $0.09B 33.58%
2019-03-31 $0.26B $0.09B 33.33%
2018-12-31 $0.25B $0.09B 35.06%
2018-09-30 $0.24B $0.09B 36.71%
2018-06-30 $0.22B $0.08B 36.11%
2018-03-31 $0.19B $0.07B 36.84%
2017-12-31 $0.16B $0.05B 33.75%
2017-09-30 $0.13B $0.04B 28.24%
2017-06-30 $0.11B $0.03B 23.64%
2017-03-31 $0.09B $0.02B 15.96%
2016-12-31 $0.08B $0.01B 13.41%
2016-09-30 $0.07B $0.01B 10.96%
2016-06-30 $0.06B $0.01B 7.81%
2016-03-31 $0.06B $0.00B 3.57%
2015-12-31 $0.05B $0.00B -6.00%
2015-09-30 $0.04B $-0.01B -18.18%
2015-06-30 $0.04B $-0.01B -34.21%
2015-03-31 $0.03B $-0.02B -59.38%
2014-12-31 $0.03B $-0.03B -107.69%
2014-09-30 $0.02B $-0.04B -166.67%
2014-06-30 $0.02B $-0.04B -235.29%
2014-03-31 $0.01B $-0.04B -338.46%
2013-12-31 $0.01B $-0.04B -381.82%
2013-09-30 $0.01B $-0.04B -525.00%
2013-06-30 $0.01B $-0.04B -666.67%
2013-03-31 $0.01B $-0.04B -740.00%
2009-12-31 $0.00B $-0.02B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.784B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.797B 32.19
Zoetis (ZTS) United States $69.430B 25.91
Takeda Pharmaceutical (TAK) Japan $49.193B 9.78
Daiichi Sankyo, - (DSNKY) Japan $43.987B 22.54
BeOne Medicines - (ONC) Cayman Islands $26.531B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.053B 0.00
Merck (MKKGY) Germany $16.763B 12.28
Summit Therapeutics (SMMT) United States $15.804B 0.00
Shionogi (SGIOY) Japan $15.161B 15.19
United Therapeutics (UTHR) United States $12.961B 11.47
Neurocrine Biosciences (NBIX) United States $12.439B 42.61
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.108B 0.00
Stevanato Group S.p.A (STVN) Italy $7.398B 45.24
Madrigal Pharmaceuticals (MDGL) United States $6.720B 0.00
Ionis Pharmaceuticals (IONS) United States $6.288B 0.00
Grifols, S.A (GRFS) Spain $6.216B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.222B 0.00
Hypermarcas (HYPMY) Brazil $3.059B 20.12
Crinetics Pharmaceuticals (CRNX) United States $2.693B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.647B 9.27
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.755B 0.00
ARS Pharmaceuticals (SPRY) United States $1.714B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Ocular Therapeutix (OCUL) United States $1.478B 0.00
Guardian Pharmacy Services (GRDN) United States $1.349B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.144B 22.89
Harrow (HROW) United States $1.120B 0.00
Dyne Therapeutics (DYN) United States $1.082B 0.00
Verve Therapeutics (VERV) United States $1.001B 0.00
Enliven Therapeutics (ELVN) United States $0.984B 0.00
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Ardelyx (ARDX) United States $0.938B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.856B 0.00
Elite Pharmaceuticals (ELTP) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.730B 0.00
Relay Therapeutics (RLAY) United States $0.593B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
USANA Health Sciences (USNA) United States $0.569B 12.36
KalVista Pharmaceuticals (KALV) United States $0.562B 0.00
Xencor (XNCR) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.544B 13.79
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
AleAnna (ANNA) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.466B 9.73
Organogenesis (ORGO) United States $0.464B 0.00
Oruka Therapeutics (ORKA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.411B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.05
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Heron Therapeutics (HRTX) United States $0.316B 0.00
Altimmune (ALT) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.07
Tonix Pharmaceuticals Holding (TNXP) United States $0.265B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
OmniAb (OABI) United States $0.213B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Esperion Therapeutics (ESPR) United States $0.195B 0.00
Larimar Therapeutics (LRMR) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
ProKidney (PROK) United States $0.173B 0.00
4D Molecular Therapeutics (FDMT) United States $0.172B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.134B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.102B 16.75
Nutriband (NTRB) United States $0.088B 0.00
Cassava Sciences (SAVA) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Wellgistics Health (WGRX) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.22
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Telomir Pharmaceuticals (TELO) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
BioVie (BIVI) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.10
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.62
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00